Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanjun Zhao

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
The American Journal of Cardiology|May 19, 2021
Impact of Postprocedural High-Sensitivity C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk with ST-Segment Elevation Myocardial Infarction With Percutaneous Coronary InterventionYing Wang, Xiaoxiao Zhao, Peng Zhou, et al.
European Journal of Medical Research|December 2, 2025
Prognostic value of stress hyperglycemia ratio in patients with different plaque types with acute myocardial infarctionJiannan Li, Linghan Xue, Runzhen Chen, et al.
Genomics|November 30, 2020
RNA-seq identifies circulating miRNAs as potential biomarkers for plaque rupture in patients with ST-segment elevation myocardial infarctionJiannan Li, Yu Tan, Zhaoxue Sheng, et al.
Frontiers in Cardiovascular Medicine|January 4, 2021
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary InterventionXiaoxiao Zhao, Ying Wang, Chen Liu, et al.
Mediators of Inflammation|May 8, 2020
Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary InterventionRunzhen Chen, Chen Liu, Peng Zhou, et al.
Platelets|October 25, 2019
Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75-100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) studyJiannan Li, Zhaoxue Sheng, Yu Tan, et al.
Frontiers in Cardiovascular Medicine|March 1, 2021
The Association Between Plasma Hyaluronan Level and Plaque Types in ST-Segment-Elevation Myocardial Infarction PatientsJiannan Li, Yu Tan, Zhaoxue Sheng, et al.
Polish Archives of Internal Medicine|April 7, 2021
Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus: a systematic review and meta-analysisRunzhen Chen, Jinying Zhou, Chen Liu, et al.
The American Journal of Cardiology|December 31, 2018
Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial InfarctionZhaoxue Sheng, Yu Tan, Chen Liu, et al.
Thrombosis Journal|May 8, 2021
Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort studyRunzhen Chen, Chen Liu, Peng Zhou, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
The American Journal of Cardiology|May 19, 2021
Impact of Postprocedural High-Sensitivity C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk with ST-Segment Elevation Myocardial Infarction With Percutaneous Coronary InterventionYing Wang, Xiaoxiao Zhao, Peng Zhou, et al.
European Journal of Medical Research|December 2, 2025
Prognostic value of stress hyperglycemia ratio in patients with different plaque types with acute myocardial infarctionJiannan Li, Linghan Xue, Runzhen Chen, et al.
Genomics|November 30, 2020
RNA-seq identifies circulating miRNAs as potential biomarkers for plaque rupture in patients with ST-segment elevation myocardial infarctionJiannan Li, Yu Tan, Zhaoxue Sheng, et al.
Frontiers in Cardiovascular Medicine|January 4, 2021
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary InterventionXiaoxiao Zhao, Ying Wang, Chen Liu, et al.
Mediators of Inflammation|May 8, 2020
Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary InterventionRunzhen Chen, Chen Liu, Peng Zhou, et al.
Platelets|October 25, 2019
Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75-100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) studyJiannan Li, Zhaoxue Sheng, Yu Tan, et al.
Frontiers in Cardiovascular Medicine|March 1, 2021
The Association Between Plasma Hyaluronan Level and Plaque Types in ST-Segment-Elevation Myocardial Infarction PatientsJiannan Li, Yu Tan, Zhaoxue Sheng, et al.
Polish Archives of Internal Medicine|April 7, 2021
Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus: a systematic review and meta-analysisRunzhen Chen, Jinying Zhou, Chen Liu, et al.
The American Journal of Cardiology|December 31, 2018
Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial InfarctionZhaoxue Sheng, Yu Tan, Chen Liu, et al.
Thrombosis Journal|May 8, 2021
Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort studyRunzhen Chen, Chen Liu, Peng Zhou, et al.
Pageof 14